Form 10-Q NEUROCRINE BIOSCIENCES For: Jun 30
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140806/A82VB22EZZ2RJ2ZZ2HZO2WXR2EQQZZ22Z26Q
Filed on: August 6, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Reiterates Buy Rating on Neurocrine Bio. (NBIX)
- Neurocrine shows two-year CRENESSITY data at ENDO 2026 medical meeting
- OneTrust Named a Visionary in the Inaugural Gartner® Magic Quadrant™ for AI Governance Platforms
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
